Professor Adam G. Dunn

Professor of Biomedical Informatics
The University of Sydney

More aggressive marketing ∝ 1/benefit-to-harm ratio

New “Law” Attempts to Explain Strategies Drug Marketers Use to Sway Prescribing, March 16, 2011, Mitka 305 (11): 1083 — JAMA

An interesting and concise new article on the influence of marketing on prescribing patterns was published online in the American Journal of Public Health and then picked up in the commentary of JAMA. It is an interesting read and does a good job of describing one of the bigger problems in the translation of evidence into practice.

from JAMA

[a picture from the JAMA commentary]

  • On the value of deplatforming, and seeing online misinformation as an opportunity to counter misinformed beliefs in front of a key audience
  • Do Twitter bots spread vaccine misinformation?
  • trial2rev: seeing the forest for the trees in the systematic review ecosystem
  • How articles from financially conflicted authors are amplified, why it matters, and how to fix it.
  • Thinking outside the cylinder: on the use of clinical trial registries in evidence synthesis communities
  • Differences in exposure to negative news media are associated with lower levels of HPV vaccine coverage